Get started
Author

Michael Ruberson Ribeiro da Silva

Observed names: Da Silva, Michael Ruberson Ribeiro, Michael R. Da Silva, Michael R. R. da Silva, Michael Ruberson Ribeiro Da Silva, Michael Ruberson Ribeiro Silva, Michael Ruberson Ribeiro da Silva, Michael Ruberson SILVA, da Silva, Michael Ruberson Ribeiro
ORCID: 0000-0003-2550-7249
Observed ORCID: 0000-0003-2550-7249
OpenAlex ID: A5016598333
Quality of life of patients with Diabetes Mellitus Types 1 and 2 from a referal health centre in Minas Gerais, Brazil
2016 · Adriana Rodrigues da Mata, Juliana Álvares, et al. · Expert Review of Clinical Pharmacology · 52
Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
2018 · Wânia Cristina da Silva, Vânia Eloisa de Araujo, et al. · BioDrugs · 51
PDF
Uso de medicamentos e fatores associados à polifarmácia em indivíduos com diabetes mellitus em Minas Gerais, Brasil
2018 · Michael Ruberson Ribeiro da Silva, Leonardo Maurício Diniz, et al. · Ciência & Saúde Coletiva · 42
PDF
Small molecule CGRP receptor antagonists for the preventive treatment of migraine: A review
2022 · Jéssica Barreto Ribeiro dos Santos, Michael Ruberson Ribeiro da Silva · European Journal of Pharmacology · 36
Self-Medication during the COVID-19 Pandemic in Brazil: Findings and Implications to Promote the Rational Use of Medicines
2023 · Patrícia Silva Bazoni, Ronaldo José Faria, et al. · International Journal of Environmental Research and Public Health · 29
PDF
Daridorexant for the treatment of insomnia disorder: findings and implications
2022 · Jéssica Barreto Ribeiro dos Santos, Michael Ruberson Ribeiro da Silva · European Journal of Clinical Pharmacology · 25
Medication Persistence for Psoriatic Arthritis in a Brazilian Real-World Setting
2019 · Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro dos Santos, et al. · Future Science OA · 22
PDF
Biological therapy in the treatment of psoriatic arthritis: economic and epidemiological considerations
2019 · Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro dos Santos, et al. · Expert Review of Clinical Immunology · 20
Comparative persistence of anti-tumor necrosis factor therapy in ankylosing spondylitis patients: a multicenter international study
2020 · Francisco de Assis Acurcio, Augusto Afonso Guerra Junior, et al. · Current Medical Research and Opinion · 18
Access to high-cost medications for psoriatic arthritis in the National Health System in Brazil: the long path up to dispensation
2019 · Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro dos Santos, et al. · Revista Brasileira de Reumatologia · 18
First line of biological drugs in rheumatoid arthritis: a medication persistence analysis
2019 · Jéssica Barreto Ribeiro dos Santos, Augusto Afonso Guerra Junior, et al. · Expert Review of Clinical Pharmacology · 16
Medication adherence and persistence of psoriatic arthritis patients treated with biological therapy in a specialty pharmacy in Brazil: a prospective observational study
2021 · Ana F. Souza, Michael R. Da Silva, et al. · Pharmacy Practice · 15
PDF
Use of medicinal plants during COVID-19 pandemic in Brazil
2023 · Alciellen Mendes da Silva, Ana Luísa Horsth, et al. · Scientific Reports · 14
PDF
Abdeg technology for the treatment of myasthenia gravis: efgartigimod drug experience
2022 · Jéssica Barreto Ribeiro Dos Santos, Rosângela Maria Gomes, et al. · Expert Review of Clinical Immunology · 13
Impact of biologic DMARDs on quality of life: 12-month results of a rheumatic diseases cohort using the Brazilian EQ-5D tariff
2020 · Haliton Alves de Oliveira Junior, Tiago Pereira da Veiga, et al. · Hospital Practice · 11
Effectiveness and safety of anti-TNF in psoriatic arthritis patients in Brazil: a post-incorporation analysis
2018 · Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro dos Santos, et al. · Journal of Comparative Effectiveness Research · 11
Cost-utility analysis of the anti-TNF therapy for rheumatoid arthritis in a real-world based model
2020 · Jéssica Barreto Ribeiro Dos Santos, Michael Ruberson Ribeiro da Silva, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 8
Effectiveness and safety of anti-TNF therapy for ankylosing spondylitis: a real-world study
2021 · Pedro Ricardo Kömel Pimenta, Michael Ruberson Ribeiro da Silva, et al. · Journal of Comparative Effectiveness Research · 7
PDF
Economic evaluation of adalimumab versus etanercept for psoriatic arthritis in a Brazilian real-world model
2021 · Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro Dos Santos, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 7
TransCon human growth hormone for children with growth hormone deficiency: a technology evaluation
2022 · Jéssica Barreto Ribeiro Dos Santos, Michael Ruberson Ribeiro Da Silva · Expert Opinion on Drug Delivery · 5
First Line of Subcutaneous Anti-tnf Therapy for Rheumatoid Arthritis: a Prospective Cohort Study
2020 · Jéssica Barreto Ribeiro Dos Santos, Michael Ruberson Ribeiro da Silva, et al. · Expert Review of Clinical Immunology · 5
Perfil epidemiológico e fatores associados à covid-19 em um município do Espírito Santo
2024 · Gabriela Vieira Fornazier, Ronaldo José Faria, et al. · Journal of Health & Biological Sciences · 3
PDF
First-line biologic therapy with tumor necrosis factor inhibitors for psoriatic arthritis: a prospective observational study
2022 · Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro dos Santos, et al. · Sao Paulo Medical Journal · 3
PDF
Conventional Synthetic Disease-Modifying Anti-rheumatic Drugs for Psoriatic Arthritis: Findings and Implications From a Patient Centered Longitudinal Study in Brazil
2022 · Ronaldo José Faria, Francisca Janiclecia Rezende Cordeiro, et al. · Frontiers in Pharmacology · 3
PDF
Religious Dynamics and Transitions in Brazil: Insights from National Census Data
2025 · Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro dos Santos · International Journal of Latin American Religions · 2
Works count: 78
Citation count: 453
H-index: 13
I10-index: 16
Year
Topic
Type